Cyclic peptides having melanocortin-4 receptor agonist activity

Details for Australian Patent Application No. 2001284026 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Yagaloff, Keith Alan; Chu, Xin-Jie; Wang, Yao; Swistok, Joseph; Cheung, Adrian Wai-Hing; Chen, Li; Danho, Waleed

Agent Spruson & Ferguson

Pub. Number AU-B-2001284026

PCT Pub. Number WO02/18437

Priority 60229184 30.08.00 US

Filing date 21 August 2001

Wipo publication date 13 March 2002

Acceptance publication date 1 March 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/68 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 March 2007 Application Accepted

  Published as AU-B-2001284026

28 June 2007 Standard Patent Sealed

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001284027

2001284025